THOMAS BROWNING: Open Payments
NPI 1770617060 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 15 payments from 9 companies in 2025. Trend: 2023 $226 · 2024 $411 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $91 |
| Dexcom, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: Dexcom G6 Transmitter, PREVNAR 20, MOUNJARO, FREESTYLE LIBRE, Cologuard Collection Kit, VRAYLAR, Ozempic, Auvelity.
Industry payments across TX — which companies pay providers there.
